ThromboGenics Struggles to Find Patients for Phase II Eye Disease Trial Post author:Sam Post published:December 7, 2017 Post category:BioPharma Resources redirected to progress new drug candidates to clinic in H1 2018. Source: BioSpace You Might Also Like Unwanted Light Shines on AstraZeneca and Its Blockbuster Seroquel December 6, 2017 Windtree Therapeutics Reports Second Quarter 2017 Financial Results August 21, 2017 Big Pharmas are Poaching Top Talent From Tech Giants Like Google and October 12, 2017
